Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 11Heart Failure 2Inflammation 1Hyperinsulinism 1Hyperglycemia 1Hereditary Sensory and Autonomic Neuropathies 1Cardiotoxicity 1

Interventions

Carvedilol 3sacubitril and valsartan sodium hydrate drug combination 2dapagliflozin 2pertuzumab 1nicotinamide-beta-riboside 1empagliflozin 1candesartan 1Trastuzumab 1Specimen Handling 1Secondary Prevention 1Perindopril 1Ogivri 1Metoprolol 1Exercise 1Electronic Health Records 1Echocardiography 1Carnitine 1Bisoprolol 1Adrenergic beta-Antagonists 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Heart Failure × dapagliflozin × Breast × Clear all
NCT07245069 2025-11-24

Alpaca

University Medical Centre Ljubljana

Phase 2 Recruiting
100 enrolled
Breast

Breast Neoplasms, Heart Failure, Inflammation

NCT06304857 2024-12-04

PROTECTAA

4th Military Clinical Hospital with Polyclinic, Poland

Phase 3 Recruiting
188 enrolled
Breast

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡